A股異動 | 醫療器械股走強 血氧儀多型號斷貨+漲價
格隆匯12月26日丨醫療器械股走強,康泰醫學漲5%,ST東洋、可孚醫療漲4%,魚躍醫療、樂普醫療漲3%。消息面上,血氧儀面臨着缺貨、預售時間長和漲價等挑戰。近日搜索各大電商平台發現,目前僅在少數店鋪能下單到可立即發貨的血氧儀,大部分店鋪出現血氧儀多個型號斷貨現象,部分型號處於預售狀態,發貨時間在2至15天不等。以投資者身份致電多家佈局血氧儀業務的上市公司,有不少公司表示當前血氧儀產品需求較緊張,公司普遍反映正加緊血氧儀產品供應、擴大產能。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.